MEGAN ASHER: Open Payments
NPI 1871091629 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,218 in 45 payments from 18 companies in 2025. Trend: 2023 $771 · 2024 $732 · 2025 $1,218
Food & beverage: $1,218
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 12 | $509 |
| Aimmune Therapeutics, Inc. | 6 | $102 |
| ABBVIE INC. | 3 | $78 |
| GlaxoSmithKline, LLC. | 3 | $64 |
| Amgen Inc. | 3 | $64 |
| Novo Nordisk Inc | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Lundbeck LLC | 2 | $34 |
| Radius Health, Inc. | 1 | $32 |
| Axsome Therapeutics, Inc. | 1 | $32 |
Products named: SPRAVATO, REXULTI, OTEZLA, ZENPEP, VRAYLAR, Ozempic, VOWST, Tymlos.
Industry payments across CA — which companies pay providers there.
